Efficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases

Area of Science:

• Biochemistry
• Cardiology
• Pharmacology

Background:

• Imbalances in reactive oxygen species (ROS) homeostasis damage metabolic and physiological processes, contributing to cardiovascular diseases (CVD).
• Mitochondrial dysfunction is a primary source of ROS, impacting cellular health and energy production.
• Cardiovascular metabolism and disease progression are intricately linked to oxidative stress and mitochondrial function.

Purpose of the Study:

• To review the role of bioactive compounds in modulating cardiovascular metabolism.
• To explore the potential of bioactive compounds in managing cardiovascular diseases (CVD).
• To discuss how bioactive compounds influence ROS homeostasis and mitochondrial dynamics.

Main Methods:

• Literature review of studies on bioactive compounds and cardiovascular health.
• Analysis of research on the impact of bioactive compounds on inflammatory pathways and ROS.
• Examination of evidence linking bioactive compounds to mitochondrial dynamics, autophagy, and energy metabolism.

Main Results:

• Bioactive compounds demonstrate immunomodulatory functions by regulating inflammatory pathways and ROS homeostasis.
• These compounds influence mitochondrial dynamics, affecting cellular autophagy and energy metabolism.
• Evidence suggests bioactive compounds impact CVD pathophysiology through metabolism, immune modulation, and circadian rhythm regulation.

Conclusions:

• Bioactive compounds offer a promising therapeutic avenue for cardiovascular diseases (CVD) by targeting metabolic and oxidative stress pathways.
• Modulating mitochondrial function and inflammation with bioactive compounds can protect cardiac health.
• Further research into bioactive compounds' multifaceted roles in metabolism, immunity, and circadian rhythms is warranted for effective CVD management.